Cogent Biosciences, Inc. (COGT)

36.72 -0.62 (-1.66%) USD  |  NASDAQ  |  Feb 23, 14:42
More

Cogent Biosciences Price Target Num Estimates

Price Target Num Estimates Chart

View Price Target Num Estimates for COGT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price Target Num Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Price Target Num Estimates Range, Past 5 Years

View Price Target Num Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price Target Num Estimates Benchmarks

View Price Target Num Estimates Benchmarks
Start Trial
Merck & Co., Inc. Upgrade
Sarepta Therapeutics, Inc. Upgrade
Cidara Therapeutics, Inc. Upgrade
BridgeBio Pharma, Inc. Upgrade
Olema Pharmaceuticals, Inc. Upgrade